Cryoport, Inc. (CYRX)
NASDAQ: CYRX · Real-Time Price · USD
7.67
+0.52 (7.27%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cryoport Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 225.61 | 233.26 | 237.28 | 222.61 | 78.7 | 33.94 | Upgrade
|
Revenue Growth (YoY) | -6.26% | -1.70% | 6.59% | 182.87% | 131.85% | 72.94% | Upgrade
|
Cost of Revenue | 131.11 | 133.92 | 133.4 | 126.03 | 42.36 | 16.59 | Upgrade
|
Gross Profit | 94.49 | 99.33 | 103.87 | 96.58 | 36.33 | 17.35 | Upgrade
|
Selling, General & Admin | 148.5 | 139.94 | 117.89 | 97.56 | 46.66 | 31.29 | Upgrade
|
Research & Development | 19.3 | 18.04 | 15.72 | 16.84 | 9.48 | 3.74 | Upgrade
|
Operating Expenses | 167.8 | 157.98 | 133.61 | 114.41 | 56.14 | 35.03 | Upgrade
|
Operating Income | -73.31 | -58.64 | -29.74 | -17.83 | -19.81 | -17.68 | Upgrade
|
Interest Expense | -5.25 | -5.5 | -6.14 | -4.69 | -2.56 | -1.37 | Upgrade
|
Interest & Investment Income | 10.87 | 10.58 | 8.47 | 3.25 | 0.76 | 0.58 | Upgrade
|
Currency Exchange Gain (Loss) | -4.23 | -2.7 | -5.3 | -10.7 | - | - | Upgrade
|
Other Non Operating Income (Expenses) | 4.05 | 3.87 | 6.47 | 7.88 | -0.68 | 0.29 | Upgrade
|
EBT Excluding Unusual Items | -67.86 | -52.4 | -26.24 | -22.09 | -22.29 | -18.17 | Upgrade
|
Merger & Restructuring Charges | -2.45 | -6.95 | -2.17 | - | -10.2 | - | Upgrade
|
Impairment of Goodwill | -104.13 | -49.57 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | 2.15 | 1.24 | -11.51 | - | -0.25 | -0.1 | Upgrade
|
Asset Writedown | -9.25 | - | - | - | - | - | Upgrade
|
Other Unusual Items | 8.71 | 5.68 | - | -251.75 | - | - | Upgrade
|
Pretax Income | -172.83 | -99.35 | -35.09 | -273.84 | -32.74 | -18.27 | Upgrade
|
Income Tax Expense | -0.29 | 0.24 | 2.24 | 1.69 | -0.05 | 0.06 | Upgrade
|
Net Income | -172.54 | -99.59 | -37.33 | -275.53 | -32.69 | -18.33 | Upgrade
|
Preferred Dividends & Other Adjustments | 8 | 8 | 8 | 8.2 | 42.34 | - | Upgrade
|
Net Income to Common | -180.54 | -107.59 | -45.33 | -283.72 | -75.03 | -18.33 | Upgrade
|
Shares Outstanding (Basic) | 49 | 49 | 49 | 46 | 39 | 33 | Upgrade
|
Shares Outstanding (Diluted) | 49 | 49 | 49 | 46 | 39 | 33 | Upgrade
|
Shares Change (YoY) | 1.11% | -0.51% | 6.66% | 19.04% | 15.54% | 18.37% | Upgrade
|
EPS (Basic) | -3.68 | -2.21 | -0.93 | -6.18 | -1.94 | -0.55 | Upgrade
|
EPS (Diluted) | -3.68 | -2.21 | -0.93 | -6.18 | -1.94 | -0.55 | Upgrade
|
Free Cash Flow | -39.11 | -39.54 | -23.96 | -15.76 | -23.78 | -6.66 | Upgrade
|
Free Cash Flow Per Share | -0.80 | -0.81 | -0.49 | -0.34 | -0.62 | -0.20 | Upgrade
|
Gross Margin | 41.88% | 42.59% | 43.78% | 43.38% | 46.17% | 51.12% | Upgrade
|
Operating Margin | -32.49% | -25.14% | -12.53% | -8.01% | -25.17% | -52.07% | Upgrade
|
Profit Margin | -80.03% | -46.12% | -19.11% | -127.45% | -95.34% | -54.01% | Upgrade
|
Free Cash Flow Margin | -17.33% | -16.95% | -10.10% | -7.08% | -30.22% | -19.62% | Upgrade
|
EBITDA | -43.92 | -31.16 | -6.97 | 2.42 | -9.94 | -15.26 | Upgrade
|
EBITDA Margin | -19.47% | -13.36% | -2.94% | 1.09% | -12.63% | -44.96% | Upgrade
|
D&A For EBITDA | 29.39 | 27.49 | 22.77 | 20.25 | 9.87 | 2.42 | Upgrade
|
EBIT | -73.31 | -58.64 | -29.74 | -17.83 | -19.81 | -17.68 | Upgrade
|
EBIT Margin | -32.49% | -25.14% | -12.53% | -8.01% | -25.17% | -52.07% | Upgrade
|
Revenue as Reported | 225.61 | 233.26 | 237.28 | 222.61 | 78.7 | 33.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.